Acarix A/S is based on pioneering research performed at the Aalborg University, Denmark, initiated in 2004. The research group received the award, ‘MedicoPrisen’, from Medicoindustrien (Danish Medtech trade association) in 2007. A research and development collaboration was established in 2007 between Aalborg University and Coloplast A/S, receiving public support from the Danish National Advanced Technology Foundation in 2008.
Acarix A/S was established in 2009 as a spin-out company from Coloplast A/S with Coloplast A/S and Aalborg University as the major shareholders. In 2010 Acarix A/S succeeded attracting venture capital from Seed Capital (DK), Sunstone Capital (DK) and Seventure Partners (F). In 2011 Acarix A/S and collaborators furthermore achieved funding of 5.3 million DKK from the Danish Business Innovation Fund.
Acarix can be reached by email at firstname.lastname@example.org for general questions or information.
Requests for information on the company, financial or clinical/technical issues can also be forwarded directly to CEO Søren Rysholt Christiansen, CFO Christian Lindholm or COO Claus Bo Vöge Christensen respectively.
We try to answer promptly and within 24 hours.
Our Management Team